Thursday, 19 April 20185:30-8:30 pm ESTHyatt House Branchburg3141 Route 22 EastBranchburg, NJ 08876+1 908 704 2191
Generic drug user fees make it possible for FDA and industry to continue to ensure that the American public has access to safe and high quality generic drugs and products. The implementation of the Generic Drug User Fee Amendments (GDUFA) encompasses a wide range of activities that fall within the scope of regulating the generic drug industry.
Topics to be covered will include:
The RAPS New York/New Jersey chapter invites you to join others from the local regulatory community to explore this important topic with your colleagues. Light refreshments will be available to all attendees. RAC holders may claim two RAC recertification credits.
Featured speaker:Scott Tomsky, MS, vice president, generics regulatory affairs, North America, Teva Pharmaceuticals
Registration Information:RAPS Member: $35List: $50